We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Medica 2024 Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Industry

Middle East In Vitro Diagnostics Market Worth USD3.4 Billion by 2021

The Middle East market for in vitro diagnostics will be worth USD 3.4 billion by 2021 and record a growth that is one and one-half to double that of the world IVD market. The growth will be driven by expanding populations and a commitment to healthcare spending in this region, which houses offices of most global concerns in Saudi Arabia, Egypt, Dubai or other locales to service this population with testing products and supplies. More...
14 Oct 2016

Danaher Corporation to Acquire Phenomenex

Danaher Corporation will acquire Phenomenex Inc., a privately held manufacturer and distributor of high-value consumables for the separation sciences, including proprietary chromatography consumables for the liquid and gas chromatography market. More...
14 Oct 2016

Instrumentation Laboratory Acquires CA Casyso

Instrumentation Laboratory (IL), which manufactures instruments and reagents for the global hemostasis market, has acquired CA Casyso AG (Basel, Switzerland) and its Tem subsidiaries (Tem), a provider of in vitro diagnostic (IVD) testing for patient blood management (PBM). More...
26 Sep 2016

Danaher to Acquire Cepheid for USD 4 Billion

Danaher Corporation will acquire Cepheid by purchasing all of the company’s outstanding shares for $53.00 per share in cash, or a total enterprise value of approximately USD 4 billion, including indebtedness and net of acquired cash. More...
07 Sep 2016

Global In Vitro Diagnostic Test Market Worth USD 60 Billion

The global in vitro diagnostic (IVD) test market is currently worth USD 60.5 billion and will continue to grow, though a moderate and gradual change is likely to be witnessed over the next five to ten years, as more opportunities are created in novel tests and growing regions, while the traditional categories and reliable large markets face challenges. More...
26 Aug 2016

Critical Care Diagnostics Market Worth USD 1.29 Billion By 2024

The global critical care diagnostics (CCD) market will grow at a lucrative rate over the next few years to reach USD 1.29 billion by 2024, driven by the rapid awareness and acknowledgment of these tests by physicians and patients, rise in geriatric population and chronic health conditions, use of telehealth services in remote areas, and technological advancements. However, increased cost of molecular diagnostics and shortage of skilled labor to handle new platforms are expected to hinder the industry’s growth. More...
16 Aug 2016

LabCorp to Acquire Sequenom

Laboratory Corporation of America Holdings (LabCorp) (Burlington, NC, USA), a healthcare diagnostics company, and Sequenom, Inc. (San Diego, CA, USA), which is in the business of non-invasive prenatal testing (NIPT) for reproductive health, have entered into a definitive agreement and plan of merger. More...
01 Aug 2016
New
Gold Member
C-Reactive Protein Reagent
CRP Ultra Wide Range Reagent Kit
Automated Blood Typing System
IH-500 NEXT
New
Automatic Biochemistry Analyzer
Audmax 180 Evolution
New
17 Beta-Estradiol Assay
17 Beta-Estradiol Assay


LabMedica Industry News channel reports on mergers and takeovers, on cooperative agreements and on trends in the IVD industry worldwide.